Paediatric non-Hodgkin lymphoma in low and middle income countries

Area of Science:

• Pediatric Oncology
• Hematology
• Global Health

Background:

• Significant advancements in treating childhood non-Hodgkin lymphoma (NHL) have led to over 85% cure rates in high-income countries (HIC).
• Conversely, cure rates for paediatric NHL in low- and middle-income countries (LMIC) remain below 50%.
• Over 90% of global paediatric NHL cases occur in LMIC, highlighting the urgent need for improved treatment strategies.

Purpose of the Study:

• To identify key issues and strategies for improving paediatric NHL outcomes in LMIC.
• To discuss the potential for bidirectional benefits from international collaborations in paediatric NHL research and treatment.
• To leverage data from the Fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma (2015).

Main Methods:

• Review and discussion of challenges and potential solutions for paediatric NHL in LMIC.
• Analysis of data and insights presented at the 2015 Varese International Symposium.
• Exploration of collaborative models between HIC and LMIC.

Main Results:

• Paediatric NHL cure rates show a stark disparity between HIC (>85%) and LMIC (<50%).
• LMIC bear the overwhelming majority (>90%) of the global paediatric NHL burden.
• The article outlines critical factors influencing treatment outcomes in resource-limited settings.

Conclusions:

• Improving paediatric NHL outcomes in LMIC is essential to reduce the global disease burden.
• International collaboration can offer mutual benefits for patients and healthcare systems in both HIC and LMIC.
• Targeted strategies are needed to bridge the gap in paediatric NHL treatment efficacy worldwide.